Raymond James Financial
BIIB icon

Raymond James Financial’s Biogen BIIB Stock Holding History

Raymond James Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
108,174
+11,475
+12% +$2.2M 0.01% 1445
2026
Q1 		$17.7M Buy
96,699
+12,985
+16% +$2.39M 0.01% 1565
2025
Q4 		$14.7M Buy
83,714
+30,372
+57% +$4.96M ﹤0.01% 1664
2025
Q3 		$7.47M Buy
53,342
+1,345
+3% +$182K ﹤0.01% 2152
2025
Q2 		$6.53M Buy
51,997
+10,034
+24% +$1.25M ﹤0.01% 2185
2025
Q1 		$5.74M Sell
41,963
-100,005
-70% -$14.3M ﹤0.01% 2241
2024
Q4 		$21.7M Buy
+141,968
New +$23.9M 0.01% 1243

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial's BIIB Position: Q2 2026 in Review

Raymond James Financial increased its Biogen (BIIB) stake by 12% in Q2 2026, buying an estimated $2.2M and bringing the position to 108,174 shares worth $23.4M. The position accounts for 0.01% of the portfolio, ranked #1445.

Raymond James Financial first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,047 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Raymond James Financial held 108,174 shares of Biogen worth $23.4M as of Q2 2026.
  • Raymond James Financial bought 11,475 Biogen shares in Q2 2026, an estimated $2.2M.
  • Biogen made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1445 holding.
  • Raymond James Financial first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,047 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.